Regulation of HAM function by proteolytic processing
Regulation of HAM function by proteolytic processing
批准号:
13680709
负责人:
MIYAZAWA Keiji
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
肝细胞生长因子激活物抑制物(HAI-1)是肝细胞生长因子激活物(HGFA)的一种蛋白类抑制物,能蛋白水解性激活肝细胞生长因子(HGF)。HGF是一种多功能细胞因子,参与损伤后的再生和组织修复。HAI-1是以I型膜蛋白的形式合成的,经蛋白分解后分泌为40kD或58kD的HAI-1。40kD的HAI-1含有一个kunitz域(Kunitz1),而58kD的HAI-1含有两个kunitz域(kunitz1和2)。我们构建了每一个kunitz域的缺失突变体,发现kunitz1主要参与对HGFA的抑制。尽管58kD的HAI-1含有两个kunitz结构域,但其对HGFA的抑制活性很弱。我们发现,当大鼠三分之二的肝脏被切除时,残留肝脏中的前HGF急剧增加,但活性HGF仅存在于少量。然后在肝部分切除后24小时经门静脉给予活性HGFA,并检测其对肝再生的影响。给予HGFA可激活残留肝脏中的前HGF,并诱导c-Met(HGF受体)的酪氨酸磷酸化。此外,肝细胞的标记指数增加,促进肝质量的恢复。然而,我们需要大量的HGFA才能显著促进肝再生,这表明组织源抑制物如HAI-1在体内调节HGFA的活性方面发挥着重要作用。
英文摘要
HGF activator inhibitor (HAI-1) is a proteinaceous inhibitor of HGF activator (HGFA), which proteolytically activates hepatocyte growth factor (HGF). HGF is a multifunctional cytokine that is involved in regeneration and tissue repair after injury. HAI-1 is synthesized as a type I membrane protein, and secreted as a 40 kD HAI-1 or 58 kD HAI-1 by proteolytic processing. 40kD HAI-1 contains one Kunitz domain (Kunitz 1), whereas 58 kD HAI-1 contains two Kunitz domains (Kunitz 1 and 2). We generated deletion mutants of each Kunitz domains, and found that Kunitz 1is mainly involved in inhibition of HGFA. Although 58 kD HAI-1contains two Kunitz domains, its inhibitory activity for HGFA is very weak. We found that two Kunitz domains masked each other, thus lowering the inhibitory activity of the whole protein.When two-thirds of rat liver is resected, pro-HGF in the residual liver increases dramatically, but the active HGF is present in only a small amount. We then administered active HGFA via portal vein 24 h after partial hepatectomy, and examined the effect on liver regeneration. Administration of HGFA caused activation of pro-HGF in the residual liver and induced tyrosine phosphorylation of c-Met (HGF receptor). In addition, labeling index of hepatocytes was increased, and recovery of liver mass was promoted. We needed, however, a large amount of HGFA to obtain significant enhancement of liver regeneration, indicating that tissue-derived inhibitors such as HAI-1 play important roles in regulating activity of HGFA in vivo.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Itoh, H., et al.: "Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP)"Biochem. Biophys. Res. Commum.. 288. 390-399 (2001)
Itoh, H., et al.:“肝细胞生长因子激活剂抑制剂 2 型 (HAI-2) 相关小肽 (H2RSP) 的鉴定”Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Denda, K. et al.: "Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1"J.Biol.Chem.. 277. 14053-14059 (2002)
Denda, K. 等人:“肝细胞生长因子激活剂抑制剂 1 型中 Kunitz 结构域的功能表征”J.Biol.Chem.. 277. 14053-14059 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kaibori, M. et al.: "Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis"J.Surg.Res.. 106. 108-114 (2002)
Kaibori, M. 等人:“肝硬化大鼠中肝细胞生长因子前体激活至其成熟形式的损伤”J.Surg.Res.. 106. 108-114 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kataoka, H., Itoh, H., Shimomura, T., Nuki, Y., Naganuma, S., and Miyazawa, K.: "Regulation of hepatocyte growth factor (HGF) activation on cell surface : Insights into an emerging class of cell surface protease inhibitors"LifeXY. 1. 1036-1042 (2001)
Kataoka, H.、Itoh, H.、Shimomura, T.、Nuki, Y.、Naganuma, S. 和 Miyazawa, K.:“细胞表面肝细胞生长因子 (HGF) 激活的调节:对新兴类别的见解
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kaibori, M. et al.: "Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF"Biochem. Biophys. Res. Commun. 290. 475-481 (2002)
Kaibori, M. 等人:“外源性施用 HGF 激活剂通过产生生物活性 HGF 增强肝脏再生”Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Development of a method to detect heterogeneity of Smad transcriptional complexes
-
批准号:17K19589
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.16万
-
财政年份:2017
-
负责人:MIYAZAWA Keiji
-
依托单位:
Development of cell-response selective regulation of TGF-βsignaling
-
批准号:22390052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:MIYAZAWA Keiji
-
依托单位:
Molecular basis of the signaling networks that regulate vasculogenesis
-
批准号:17570106
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:MIYAZAWA Keiji
-
依托单位:
Molecular mechanism of vascular endothelial/mural cell differentiation by receptor tyrosine kinases
-
批准号:15570110
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:MIYAZAWA Keiji
-
依托单位:
Use of hepatocyte growth factor activator for limited digestion of tagged fusion proteins
-
批准号:11557181
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.32万
-
财政年份:1999
-
负责人:MIYAZAWA Keiji
-
依托单位:
Mechanism of ligand : receptor complex assembly of platelet-derived growth factor (PDGF)
-
批准号:10680602
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1998
-
负责人:MIYAZAWA Keiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
-
批准号:31040083
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:肖调义
-
依托单位:
熊胆粉中具抗丙型肝炎病毒作用的大分子蛋白纯化鉴定及药理学特性研究
-
批准号:30973886
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:王喜军
-
依托单位:
铁螯合剂对蛋白酶体抑制剂所致神经元变性的拮抗作用
-
批准号:30670748
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2006
-
负责人:张雄
-
依托单位: